Quinine therapy and peritoneal dialysis in acute renal failure complicating malarial haemoglobinuria.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 4169971)

Published in Lancet on February 24, 1968

Authors

J V Donadio, A Whelton, L Kazyak

Articles by these authors

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA (2000) 20.35

Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol (1997) 2.12

A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. Clin Ther (2001) 1.78

Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis (1999) 1.67

Editorial: Intrarenal antibiotic distribution in health and disease. Kidney Int (1974) 1.46

Renal biopsy in clinical practice. Mayo Clin Proc (1994) 1.39

Complications of percutaneous renal biopsy: an analysis of 1,000 consecutive biopsies. Clin Nephrol (1975) 1.22

Therapeutic implications of gentamicin accumulation in severly diseased kidneys. Arch Intern Med (1976) 1.21

Renal involvement in relapsing polychondritis. Medicine (Baltimore) (1987) 1.16

Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int (1987) 1.15

Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med (1972) 1.14

Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med (1984) 1.08

The risks of unilateral nephrectomy: status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc (1985) 1.03

Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med (1978) 1.02

Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. Am J Ther (2001) 1.00

Doxycycline pharmacokinetics in the absence of renal function. Kidney Int (1974) 0.98

Intrarenal distribution of ampicillin in the normal and diseased human kidney. J Infect Dis (1972) 0.97

Renal allograft bruit. An encouraging finding. Mayo Clin Proc (1973) 0.96

Post-traumatic acute renal failure in Vietnam. A comparison with the Korean war experience. Johns Hopkins Med J (1969) 0.96

Experience with renal transplantation in high risk patients. Surg Gynecol Obstet (1973) 0.96

Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int (1974) 0.96

Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate. Am J Med (1984) 0.95

IgA-IgG nephropathy: predictive indices of progressive disease. Clin Nephrol (1981) 0.92

Intrarenal distribution of penicillin, cephalothin, ampicillin and oxytetracycline during varied states of hydration. J Pharmacol Exp Ther (1971) 0.92

Comparison of the intrarenal disposition of tobramycin and gentamicin: therapeutic and toxicologic answers. J Antimicrob Chemother (1978) 0.92

Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int (1991) 0.92

Glomerular epithelial cell changes in early postischemic acute renal failure in rabbits and man. Am J Pathol (1981) 0.92

Acute renal failure complicating rickettsial infections in glucose-6-phosphate dehydrogenase-deficient individuals. Ann Intern Med (1968) 0.92

The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc (1973) 0.92

Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc (1976) 0.91

Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int (2000) 0.91

Aminoglycoside nephrotoxicity--a tale of two transports. J Lab Clin Med (1982) 0.90

Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA (1996) 0.90

Renal function in donors and recipients of renal allotransplantation. Radioisotopic measurements. Ann Intern Med (1967) 0.90

Focal sclerosing glomerulonephropathy: a clinicopathologic study. Mayo Clin Proc (1975) 0.89

Membranous lupus nephropathy: a clinicopathologic study. Medicine (Baltimore) (1977) 0.89

Recurrent Goodpasture's syndrome. Mayo Clin Proc (1978) 0.88

Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum (1974) 0.88

Lipoprotein profiles in adult nephrotics. Mayo Clin Proc (1975) 0.88

Treatment of lupus nephritis. Nephron (1977) 0.87

Renal failure and fluorosis. JAMA (1972) 0.86

Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome. Mayo Clin Proc (1979) 0.86

Mechanisms of lysine-induced acute renal failure in rats. Kidney Int (1985) 0.86

Antibacterial chemotherapy in renal insufficiency. A review. Antibiot Chemother (1971) (1974) 0.85

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum (2000) 0.85

Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin. J Clin Pharmacol (1981) 0.84

The pathology of acute renal failure due to interstitial nephritis in man with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity. Medicine (Baltimore) (1982) 0.84

Pathogenesis of membranous nephropathy in systemic lupus erythematosus: possible role of nonprecipitating DNA antibody. Br Med J (1977) 0.84

Acyclovir kinetics in end-stage renal disease. Clin Pharmacol Ther (1982) 0.83

Cardiovascular events and COX-2 inhibitors. JAMA (2001) 0.82

Cure of cryptococcal infection during continued immunosuppressive therapy. Q J Med (1985) 0.82

High-dosage intravenously administered methylprednisolone in renal transplantation. A preliminary report. JAMA (1973) 0.82

Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy. Am J Kidney Dis (1994) 0.82

Acute renal papillary necrosis induced by ibuprofen. Am J Ther (1997) 0.81

Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine. J Lab Clin Med (1984) 0.81

Class of immunoglobulin deposition and prognosis in lupus nephritis. Mayo Clin Proc (1978) 0.81

Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study. Mayo Clin Proc (1979) 0.81

Renal transplantation in patients with diabetes mellitus. Lancet (1972) 0.81

Circulating immune complexes in systemic lupus erythematosus. Association with other immunologic abnormalities but not with changes in renal function. J Rheumatol (1978) 0.81

Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney Int (1989) 0.80

Therapeutic initiatives for the avoidance of aminoglycoside toxicity. J Clin Pharmacol (1985) 0.80

Cholestyramine-induced hyperchloremic metabolic acidosis. J Clin Pharmacol (1992) 0.80

The aminoglycosides. Clin Orthop Relat Res (1984) 0.80

Use of captopril as early therapy for renal scleroderma: a prospective study. Mayo Clin Proc (1985) 0.79

Hypertension and renal dysfunction in bone marrow transplant recipients. Q J Med (1988) 0.79

Operation of a renal center in a combat zone. Mil Med (1968) 0.79

Pharmacokinetic characteristics of doxycycline accumulation in normal and severely diseased kidneys. J Infect Dis (1975) 0.79

Acute toxic drug ingestions at the Johns Hopkins Hospital. 1963 through 1970. Johns Hopkins Med J (1973) 0.79

The position of paracetamol in the world of analgesics. Am J Ther (2000) 0.79

Post-traumatic acute renal failure in Vietnam: A milestone in progress. Conn Med (1974) 0.79

Effects of lysine and other amino acids on kidney structure and function in the rat. Am J Pathol (1985) 0.79

Calcium channel blockade in experimental aminoglycoside nephrotoxicity. J Clin Pharmacol (1987) 0.79

Dietary fish oil supplementation in IgA nephropathy: a therapy in search of a mechanism? Nutrition (1998) 0.79

Carbenicillin concentrations in normal and diseased kidneys. A therapeutic consideration. Ann Intern Med (1973) 0.78

Post-traumatic acute renal failure. Bull N Y Acad Med (1979) 0.78

Long-term bumetanide treatment of renal edema. Comparison with furosemide. J Clin Pharmacol (1982) 0.78

Carbenicillin-induced acidosis and seizures. JAMA (1971) 0.78

Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases. Arch Intern Med (1973) 0.78

The fate of renal transplants in patients with IgA nephropathy. Clin Transplant (1997) 0.78

Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure. Am J Med (1982) 0.78

Tetracyclines in renal insufficiency: resolution of a therapeutic dilemma. Bull N Y Acad Med (1978) 0.77

Neomycin toxicity revisited. Arch Surg (1976) 0.77

Cure of cryptococcemia and preservation of graft function in a renal transplant recipient. Arch Intern Med (1984) 0.77

Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity. Prog Clin Biol Res (1979) 0.76

Renal allograft arteriovenous fistula following percutaneous biopsy. J Urol (1974) 0.76

Pathophysiologic mechanisms in aminoglycoside nephrotoxicity. J Clin Pharmacol (1983) 0.76

Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract. Obstet Gynecol (1980) 0.76

Sulindac kinetics and effects on renal function and prostaglandin excretion in renal insufficiency. J Clin Pharmacol (1989) 0.76

Sulindac and renal impairment. JAMA (1983) 0.76

Antibiotic pharmacokinetics and clinical application in renal insufficiency. Med Clin North Am (1982) 0.76

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study. Mayo Clin Proc (1985) 0.76

Effect of renal failure on the pharmacokinetics of acyclovir. Am J Med (1982) 0.76

Role of dietary fish oil supplementation in IgA nephropathy. Mechanistic implications. Minerva Urol Nefrol (2001) 0.76

Cyclooxygenase-2 inhibition and renal function. Ann Intern Med (2001) 0.75

Selective inhibition of thromboxane synthesis in glycerol-induced acute renal failure. Am J Kidney Dis (1986) 0.75

Peritoneal dialysis in quinine intoxication. JAMA (1968) 0.75

An approach to the interpretation of drug concentrations in the kidney. Johns Hopkins Med J (1978) 0.75

Peritoneal dialysis in malaria. Lancet (1967) 0.75